Clinical Trial

Golidocitinib Combined With GemOx in RR PTCL

Name: Golidocitinib Combined With GemOx in RR PTCL — clinical trial record (NCT07279584)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The objective of this study is to evaluate the efficacy and safety of golidocitinib in combination with the GemOx regimen in r/r PTCL

Trial Details

NCT Number	NCT07279584
Lead Sponsor	Ruijin Hospital
Conditions	Peripheral T-cell Lymphomas (PTCL)
Enrollment	31 participants
Start Date	2025-12-20
Primary Completion	2026-12-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-12-12